Pharmasgp Holding Forecast, price target & analysts
Pharmasgp Holding Target price 2025 - Analyst rating & recommendation
Pharmasgp Holding Classifications & Recommendation:
Pharmasgp Holding Price Target
| Target Price | €39.53 |
| Price | €28.40 |
| Potential |
39.17%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Pharmasgp Holding 2026 .
The average Pharmasgp Holding target price is €39.53.
This is
39.17%
register free of charge
€41.48
46.04%
register free of charge
€38.38
35.14%
register free of charge
|
|
| A rating was issued by 6 analysts: 5 Analysts recommend Pharmasgp Holding to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Pharmasgp Holding stock has an average upside potential 2026 of
39.17%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million € | 101.10 | 115.49 |
| 17.80% | 14.23% | |
| EBITDA Margin | 33.64% | 31.66% |
| 6.81% | 5.89% | |
| Net Margin | 16.22% | 16.51% |
| 16.50% | 1.78% |
3 Analysts have issued a sales forecast Pharmasgp Holding 2024 . The average Pharmasgp Holding sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Pharmasgp Holding EBITDA forecast 2024. The average Pharmasgp Holding EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Pharmasgp Holding Analysts have issued a net profit forecast 2024. The average Pharmasgp Holding net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share € | 1.37 | 1.59 |
| 37.00% | 16.06% | |
| P/E | 17.85 | |
| EV/Sales | 3.31 |
3 Analysts have issued a Pharmasgp Holding forecast for earnings per share. The average Pharmasgp Holding EPS is
This results in the following potential growth metrics and future valuations:
Pharmasgp Holding...
Current Pharmasgp Holding Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Oct 01 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Oct 01 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
